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Background
 NASA’s Human Research Program Integrated Research Plan (HRP-47065) 
serves as a road-map identifying critically needed information for future 
space flight operations (Lunar, Martian)
 VO2max (often termed “aerobic capacity”) reflects the maximum rate at 
which oxygen can be taken up and utilized by the body during exercise
 Lack of in-flight and immediate postflight VO2max measurements was one 
area identified as a concern
 The risk associated with not knowing this information is: “Unnecessary 
Operational Limitations due to Inaccurate Assessment of Cardiovascular 
Performance” (HRP-47065)  
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Background
 Currently, VO2max is estimated using HR response to submaximal exercise
 Assumes VO2  at each exercise stage during flight same as preflight
 The validity of this technique has not been established during or after flight
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Background
 Current data suggests a sharp decline in VO2max early in-flight and a 
slow recovery with participation in exercise countermeasures
 Large decline at R+5, but recovered to preflight fitness by R+30
 Do these changes in estimated VO2max reflect true changes?
 Factors such as cycling efficiency can influence the HR and VO2 response to exercise
 Anything affecting exercise HR response also effects the VO2max estimate
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Specific Aims
 To directly measure VO2max during and following long 
duration missions
 To assess the validity of the current methods of estimating 
VO2max change during and following ISS missions, and;
 To determine if the accuracy of estimating changes in 
VO2max during and following ISS missions can be 
improved (e.g. addition of submaximal VO2, cardiac 
output measures)
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Experiment Design
Preflight In-Flight Postflight
Peak Cycle Exercise Test-
Nominal MEDB 4.1
L-270 ( 3 weeks)
1 hour
VO2max Cycle Exercise Test 
– Preflight Trial 1*
L-60 (± 5 days)
1.5 hours
VO2max Cycle Exercise Test 
– Preflight Trial 2§
L-30 (± 5 days)
1.5 hours
§If L-60 is technically sound, 
L-30 test will be waived.
VO2max Cycle Exercise Tests
FD 14 (± 2 days)
3.0 hours
(Repeated every 30 days)
VO2max Cycle Exercise 
Tests
R+1
1 hour
R+10 (± 2 days)* 
1 hour
R+30 (± 2 days)
1 hour
*Represents test session not normally performed for MEDB 4.1
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Session Descriptions
Preflight
SESSION: Peak Cycle Exercise Test on L-270 ( 3 weeks)
Scenario: (1 hour)
• Measure VO2max during a cycle protocol of increasing exercise intensity
• Heart rate, blood pressure, exercise workloads, and perception of effort will 
also be measured
• Data obtained from this test will be used to establish the protocol for the 
subsequent tests 
• Session is identical to that performed by all crew members under MEDB 
4.1
– Data will be shared between PI and Med Ops to prevent necessity for 
redundant testing
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Session Descriptions
Preflight/Postflight
SESSIONS: VO2max Cycle Exercise Tests on L-60, L-30, R+1, R+10 
and R+30
Scenario: (1.5 hours/test preflight, 1 hour/test postflight)
• Measure VO2max using investigation specific protocol
• First 3 exercise stages are 5 min @ work rates eliciting ~ 25, 50 and 75% of 
L-270 VO2max, remaining stages increase 25 W/min to maximal levels
• First 3 stages are identical to those used in MEDB 4.1 testing
• Blood pressure, oxygen uptake, heart rate, workloads and perception of 
effort will be measured
• Cardiac output will be measured using a rebreathing technique during last 
minute of the first 3 exercise stages
• Data obtained from L-60, R+1, R+30 will fulfill MEDB 4.1 testing 
requirements.
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Session Descriptions
Preflight/Postflight
Constraints:
• No max exercise 24 hrs prior to testing; no regular exercise 8 hrs prior to 
testing
• No food 2 hrs prior to test
• No caffeine, alcohol, or nicotine 8 hrs prior to test
• No Neutral Buoyancy training 48 hours prior to test; prefer 72 hours  
• ECG monitoring (up to 3 Leads) is required for tests
• No physical testing or physical training will be conducted with the 
crewmembers within 72 hours of returning from overseas travel
• No physical testing or physical training will be conducted with the 
crewmembers within 48 hours of domestic travel unless approved by the 
Crew Surgeon
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Session Descriptions
In-Flight
SESSIONS: VO2max Cycle Exercise Tests on FD 14 and every 30 
FDs subsequent (same schedule as MEDB 4.1)
Scenario: (3.0 hours/test, includes equipment and subject preparation, 
exercise and stowage time)
• Same test protocol as performed preflight
• ECG is down-linked real time during test (Ku coverage necessary during 
exercise) and viewed by Surgeon for medical monitoring purposes only
• Cardiac output will be measured using a rebreathing technique during last 
minute of the first 3 exercise stages
• Data other than ECG will be down-linked following session
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Session Descriptions
In-Flight
Constraints:
• No max exercise 24 hrs prior to testing; no regular exercise 8 hrs 
prior to testing
• No food 2 hrs prior to test
• No caffeine, alcohol, or nicotine 8 hrs prior to test
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Experiment Training
Session Title Schedule Duration
MEC OV*
CMS Ops 1*
PPFS Hardware Overview
VO2max Integrated Training
VO2max Refresher Training
L-1 year
L-1 year
L-365/180 days
L-160/120 days
L-90/45 days
1 hour
1.5 hours
2 hours
2 hours
1.5 hours
MEC OV – Medical Equipment Computer Overview
CMS Ops – Countermeasure Systems Operations
PPFS – Portable Pulmonary Function System
* Scheduled training is performed as outlined in MEDB 4.1
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Data Distribution
• In-flight real time data (ECG, HR, etc.) will be viewed 
by hardware support team to verify proper hardware 
configuration
• Experimental data will not be used to assess crew 
health
• Any data sharing will be captured in the Data Sharing 
Plan specific to that subject’s flight
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Possible Risks or Discomforts
 Study designated as “Reasonable Risk” by NASA CPHS
 Many of these are already associated with MEDB 4.1
• Muscle cramping, fatigue or soreness
• Cycling rarely produces soreness
• Warm-up and cool-down procedure mitigates risk
• Subjects encouraged to stretch following the activity
• Rash or irritation of the skin
• Due to adhesive sensitivity (electrode site)
• Request that electrode sites be washed/wiped following test
• Saddle Soreness (pre/post only)
• Padded gel seat used to minimize discomfort
• Mouth/throat dryness
• Drink water prior to and following test
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Possible Risks or Discomforts
• Electrical shock
• All testing equipment has passed both NASA safety inspections and 
manufacturing electrical tests.
• Heart problems
• Vigorous exercise always carries this risk
• Sudden death ~ 1:15,000 per year in recreational joggers, ~1:50,000 
per year in marathon participants (majority are medically unscreened 
individuals)
• Risk is mitigated by the amount of screening/testing astronauts 
receive
• Medical monitoring will be used (pre/post flight, flight surgeon will 
be present; inflight ECG monitoring/downlink will be used)
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Possible Risks or Discomforts
• Dizziness Following Exercise
• Most likely to occur on R+1, potential to occur during other ground tests
• May be due to blood pooling in legs, active cool down helps mitigate this
• Will monitor blood pressure and symptoms
• If necessary, subject will be moved to supine position for recovery
• Perception of “air hunger”
• Cardiac output measure done with rebreathing technique
• Elevation in bag CO2 may cause “air hunger” symptoms
• Mitigated by elevation of oxygen concentration in rebreathing gas
• Rebreathing period is short: ≤ 30 seconds; may be aborted safely if 
discomfort is extreme
• Accident Due to Improper Handling of Compressed Gas
• Crew and investigators will be/are trained on handling of compressed gas
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Experiment Success
Defined by:
 Direct and accurate measures of VO2max during and following long 
duration missions accomplished
 Determination of the accuracy of estimating VO2max using submaximal 
test results (workload vs. HR; VO2 vs. HR) 
 Determination of added benefit of cardiac output to estimates of 
VO2max from submaximal test results
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Experiment Benefits
 Direct measures of VO2max will establish the “space normal” response 
of VO2max to long duration space flight.  This will aid in future mission 
planning and act as a baseline for countermeasures assessment.
 Data will allow NASA to determine if submaximal tests provide 
accurate information to assess VO2max.  This may have implications on 
the future of routine tests conducted on the ISS and interpretation of 
data previously collected during long duration missions. 
 Will determine if the addition of the non-invasive measurement of 
cardiac output improves the estimate of VO2max derived from 
submaximal test results.
